瑞信：維持啓明醫療-B“跑贏大市” 評級 目標價 100 港元

智通財經
2021.07.05 02:04
智通財經 APP 獲悉，瑞信發佈研究報告，維持啓明醫療-B(02500)“跑贏大市” 評級，目標價 100 港元，公司今年首 5 個月已完成 1500 個經導管主動脈瓣置換術 (TAVR) 相關手術，預計上半年手術量可達到 1900 個。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.